A New Milestone: 25% Human Albumin Injection Approved in China — A Breakthrough in Critical Care
At Dengyuemed, we closely follow breakthroughs in essential therapeutics and innovative drug developments. Dengyue is…
News
What Are The 5 Warning Signs of Bladder Cancer?
Bladder cancer is a serious but often treatable condition when caught early. Recognizing the early…
China Releases 2025 Clinical Guidelines for 86 Rare Diseases
Source: Dengyuemed | July 11, 2025 | Category: Rare Diseases On July 10, the General…
U.S. vs. China: 10 of The Most Expensive Orphan Drug List 2025
Introduction Do you know that designed to treat rare, life-threatening diseases, the orphan drug list…
Innovative Corneal Storage Bring New Hope to Patients with Corneal Blindness
On June 27, the corneal storage solution developed by the team at the Affiliated Eye…
Trailblazing Therapy: IBR900 Cellular Injection Enters Phase I Trial
On July 1, 2025, the initiation meeting for the Phase I clinical trial of IBR900…
Complicated Intra Abdominal Infections Guidelines
Introduction One hundred years ago, the mortality rate from complicated intra abdominal infections (cIAI) was…
Is Multiple Sclerosis Stealing Your Energy—Or Just Your Focus?
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS),…
Is Chronic Hepatitis C Curable? Discover 6 Vital Facts
Introduction Millions of Americans are infected with hepatitis C and don’t even know it. Hepatitis…
Dato DXd (ADC) Approved by U.S. FDA for Lung Cancer
Dato DXd (datopotamab deruxtecan) has received U.S. FDA approval – a breakthrough milestone announced jointly…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights